OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Sung Yong Park, Hanpyo Hong, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 120-134
Open Access | Times Cited: 34
Young Eun Chon, Sung Yong Park, Hanpyo Hong, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 120-134
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 355-357
Open Access | Times Cited: 72
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 355-357
Open Access | Times Cited: 72
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 20
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 20
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 684-684
Open Access | Times Cited: 9
Michael H. Storandt, Sri Harsha Tella, Mikolaj A. Wieczorek, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 684-684
Open Access | Times Cited: 9
Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and/or alcohol: a nationwide study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Clinical Course and Prognosis of Long‐Term Survivors of Hepatocellular Carcinoma
Soon Sun Kim, Jonghyun Lee, Sang Bong Ahn, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Soon Sun Kim, Jonghyun Lee, Sang Bong Ahn, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 7
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 7
Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
Osama A. Mohammed, Ahmed S. Doghish, Lobna A. Saleh, et al.
Pathology - Research and Practice (2024) Vol. 253, pp. 155086-155086
Closed Access | Times Cited: 5
Osama A. Mohammed, Ahmed S. Doghish, Lobna A. Saleh, et al.
Pathology - Research and Practice (2024) Vol. 253, pp. 155086-155086
Closed Access | Times Cited: 5
Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, et al.
Chemistry & Biodiversity (2025)
Closed Access
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, et al.
Chemistry & Biodiversity (2025)
Closed Access
Targeting glypican 3 by Immunotoxins; the promise of immunotherapy in hepatocellular carcinoma
Elham Rismani, Nikoo Hossein‐Khannazer, Moustapha Hassan, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
Elham Rismani, Nikoo Hossein‐Khannazer, Moustapha Hassan, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
A Prospective, Multicenter, Randomized, Noninferiority Trial of Stopad® Versus Tachosil® for Hemostasis After Liver Resection
Sung Yoon Lim, Gi Hong Choi, Jin Hong Lim, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 757-757
Open Access
Sung Yoon Lim, Gi Hong Choi, Jin Hong Lim, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 757-757
Open Access
Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
Huiyul Park, Eileen L. Yoon, Takanori Ito, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329568-e2329568
Open Access | Times Cited: 12
Huiyul Park, Eileen L. Yoon, Takanori Ito, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2329568-e2329568
Open Access | Times Cited: 12
Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology (2023) Vol. 29, Iss. 27, pp. 4271-4288
Open Access | Times Cited: 4
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology (2023) Vol. 29, Iss. 27, pp. 4271-4288
Open Access | Times Cited: 4
Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jeong‐Ju Yoo, Sujin Koo, Gi Hong Choi, et al.
Current Oncology (2024) Vol. 31, Iss. 1, pp. 324-334
Open Access | Times Cited: 1
Jeong‐Ju Yoo, Sujin Koo, Gi Hong Choi, et al.
Current Oncology (2024) Vol. 31, Iss. 1, pp. 324-334
Open Access | Times Cited: 1
Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage
Biki Saha, Sneha Pallatt, Antara Banerjee, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1560-1560
Open Access | Times Cited: 1
Biki Saha, Sneha Pallatt, Antara Banerjee, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1560-1560
Open Access | Times Cited: 1
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Reem El‐Shenawy, Rehab I. Moustafa, Naiera M. Helmy, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Reem El‐Shenawy, Rehab I. Moustafa, Naiera M. Helmy, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong‐Won Park
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 99-101
Open Access | Times Cited: 6
Yuri Cho, Bo Hyun Kim, Joong‐Won Park
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 99-101
Open Access | Times Cited: 6
Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, et al.
Radiation Oncology Journal (2023) Vol. 41, Iss. 2, pp. 98-107
Open Access | Times Cited: 3
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, et al.
Radiation Oncology Journal (2023) Vol. 41, Iss. 2, pp. 98-107
Open Access | Times Cited: 3
A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly
Jeong‐Ju Yoo, Jayoun Lee, Gi Hong Choi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Jeong‐Ju Yoo, Jayoun Lee, Gi Hong Choi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Bioactive compound D-Pinitol-loaded graphene oxide-chitosan-folic acid nanocomposite induced apoptosis in human hepatoma HepG-2 cells
Ibrahim Abdel Aziz Ibrahim, Abdullah R. Alzahrani, Ibrahim M. Alanazi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105282-105282
Closed Access | Times Cited: 3
Ibrahim Abdel Aziz Ibrahim, Abdullah R. Alzahrani, Ibrahim M. Alanazi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 92, pp. 105282-105282
Closed Access | Times Cited: 3
The efficacy of treatment for hepatocellular carcinoma in elderly patients
Han Ah Lee, Sangheun Lee, Hae Lim Lee, et al.
Journal of Liver Cancer (2023) Vol. 23, Iss. 2, pp. 362-376
Open Access | Times Cited: 2
Han Ah Lee, Sangheun Lee, Hae Lim Lee, et al.
Journal of Liver Cancer (2023) Vol. 23, Iss. 2, pp. 362-376
Open Access | Times Cited: 2
Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation: A Retrospective Cohort Study with Propensity Score-Matched Analysis
Yeshong Park, Ho‐Seong Han, Yoo‐Seok Yoon, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4745-4745
Open Access | Times Cited: 2
Yeshong Park, Ho‐Seong Han, Yoo‐Seok Yoon, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4745-4745
Open Access | Times Cited: 2
Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go
Pil Soo Sung, Isaac Kise Lee, Pu Reun Roh, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Pil Soo Sung, Isaac Kise Lee, Pu Reun Roh, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablation.
Yi‐Hao Yen, Kwong‐Ming Kee, Chao–Hung Hung, et al.
Research Square (Research Square) (2024)
Open Access
Yi‐Hao Yen, Kwong‐Ming Kee, Chao–Hung Hung, et al.
Research Square (Research Square) (2024)
Open Access
A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection
MeeYoung Kang, Jai Young Cho, Ho‐Seong Han, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 278-278
Open Access
MeeYoung Kang, Jai Young Cho, Ho‐Seong Han, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 278-278
Open Access
Expressional and prognostic value of CRLF3 in liver hepatocellular carcinoma patients via integrated bioinformatics analyses and experiments
幸幸 王, Zhen Huang, Lili Huang, et al.
Research Square (Research Square) (2024)
Open Access
幸幸 王, Zhen Huang, Lili Huang, et al.
Research Square (Research Square) (2024)
Open Access
